Biotalys Achieves Key Milestone with Syngenta in Bioinsecticide Development
Biotalys has announced reaching an initial milestone in its research partnership with Syngenta to develop an innovative bioinsecticide. Laboratory tests have shown promising in vitro results with bioactive ingredients developed using the proprietary AGROBODY™ technology.
Collaborative Efforts Towards Bioinsecticide Solutions
Biotalys and Syngenta are collaborating to develop a bioinsecticide solution aimed at combating major crop pests. The partnership is part of a joint effort to offer crop protection solutions that combine the effectiveness of conventional products with the sustainable benefits of biological solutions. Based in Ghent, Belgium, Biotalys utilizes its AGROBODY™ technology platform for this collaboration with Syngenta, a global leader in agricultural innovation.
Promising Laboratory Results
Laboratory tests have demonstrated promising in vitro results with new bioactive ingredients developed by Biotalys targeting insecticidal molecules. The teams from both companies will proceed to the next research phase, which will involve testing the active ingredients on living organisms (in vivo tests). Syngenta will make an initial milestone payment to Biotalys, reflecting the ongoing progress of the collaboration.
Financial Impact of the Milestone Payment
The initial milestone payment from Syngenta will not materially impact the current financial autonomy of Biotalys.
